Professor Mark von Itzstein, Founder and Director of Griffith University’s Institute for Glycomics, has been awarded one of Australia’s highest...
The launch of the newly named Compounds Australia begins a program of growth and diversification to boost its collection and enhance benefits for industry and research
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic discovery capability under the leadership of Therapeutic Innovation Australia (TIA).
The Griffith Institute for Drug Discovery has become the new home for a uniquely curated library of 329,000 chemical compounds used to advance drug research in Australia.
The Queensland Government has awarded $1.875 million in funding to Compounds Australia.
Griffith University’s Eskitis Institute will be the gateway for European scientists to access potential building blocks for new drugs and other products sourced from compounds created by Australian chemistry researchers.
Lara Herrero received the Prize for New Innovators in the 2023 Prime Minister’s Prizes for Science at a ceremony in Canberra last night.
Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Two new clinical trials are set to begin at Griffith University’s Clinical Trial Unit (CTU) on the Gold Coast, as the Australian Government rolls out a new program to assist smaller companies and researchers to navigate complex regulations, in order to develop the next generation of medical devices, apps and therapeutic drugs.
Barbara Hadley has been a professional snooker player, a private investigator and a chief toilet cleaner in the Greek Islands....
